Trilantic-backed OrthoLite to explore sale next year, sources say
OrthoLite, an Amherst, Massachusetts-based manufacturer of foam insoles and footwear components, is expected to explore a sale next year, according to three sources familiar with the matter.
The Trilantic North America-backed company has appointed William Blair to advise on the potential sale effort, the sources said. Deutsche Bank is also serving as a co-advisor, two of the sources said.
The company generates roughly USD 70m in EBITDA, said all three sources, with two of them adding it has around USD 275m in revenue. The seller is currently prepping marketing materials and is expected to conduct a targeted sale process, one of the sources said.
OrthoLite has a strong management team and is a good asset, according to one of the sources. Trilantic acquired OrthoLite in 2017 from private equity firm Blue Point Capital Partners for an undisclosed amount in a process that was also led by William Blair.
Founded in 1997, Ortholite makes footwear insoles found in more than 600 million pairs of athletic, casual, work, dress, and outdoor shoes annually and delivers to over 550 footwear brand partners, according to a company press release.
Earlier this year, the company announced an expansion of its European hub in Almansa, Spain, OrthoLite Europa, which has quadrupled in capacity since 2021, according to OrthoLite.
Deutsche Bank declined to comment. OrthoLite, Trilantic and William Blair did not respond to requests for comment.